找回密碼
 To register

QQ登錄

只需一步，快速開(kāi)始

掃一掃，訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Novel Antischizophrenia Treatments; Mark A. Geyer,Gerhard Gross Book 2012 Springer-Verlag Berlin Heidelberg 2012 Cognition.Neurotransmitte

[復(fù)制鏈接]
查看: 42327|回復(fù): 53
樓主
發(fā)表于 2025-3-21 17:53:11 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Novel Antischizophrenia Treatments
編輯Mark A. Geyer,Gerhard Gross
視頻videohttp://file.papertrans.cn/669/668342/668342.mp4
概述Provide up-to-date information on approaches to the discovery of treatments for cognitive deficits in schizophrenia.Provide information on promising new targets for therapeutics in the treatment of sc
叢書(shū)名稱(chēng)Handbook of Experimental Pharmacology
圖書(shū)封面Titlebook: Novel Antischizophrenia Treatments; Mark A. Geyer,Gerhard Gross Book 2012 Springer-Verlag Berlin Heidelberg 2012 Cognition.Neurotransmitte
描述This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters?also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. The volume concentrates on reviewing the ongoing research attempting to identify novel treatments for the cognitive deficits and negative symptoms of schizophrenia, which are not treated adequately by current antipsychotic medications.
出版日期Book 2012
關(guān)鍵詞Cognition; Neurotransmitters; Psychopharmacology; Schizophrenia
版次1
doihttps://doi.org/10.1007/978-3-642-25758-2
isbn_softcover978-3-642-43809-7
isbn_ebook978-3-642-25758-2Series ISSN 0171-2004 Series E-ISSN 1865-0325
issn_series 0171-2004
copyrightSpringer-Verlag Berlin Heidelberg 2012
The information of publication is updating

書(shū)目名稱(chēng)Novel Antischizophrenia Treatments影響因子(影響力)




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments被引頻次




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments被引頻次學(xué)科排名




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments年度引用




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments年度引用學(xué)科排名




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments讀者反饋




書(shū)目名稱(chēng)Novel Antischizophrenia Treatments讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:39:42 | 只看該作者
Clinical Instruments to Evaluate and Guide Treatment in Schizophrenia,ces. This has led to the use of functional capacity measures which monitor an individual’s ability to perform functionally meaningful tasks even if they do not complete these tasks. Attention has also focused on interview-based measures of cognition and negative symptoms. Both of these psychopatholo
板凳
發(fā)表于 2025-3-22 02:30:13 | 只看該作者
地板
發(fā)表于 2025-3-22 07:54:01 | 只看該作者
5#
發(fā)表于 2025-3-22 10:03:06 | 只看該作者
Towards Medication-Enhancement of Cognitive Interventions in Schizophrenia, might be possible to significantly enhance the efficacy of cognitive therapies. We review and suggest several laboratory measures that might detect potential pro-neurocognitive effects of drugs in individual patients, using a “test dose” design, aided by specific biomarkers predicting an individual
6#
發(fā)表于 2025-3-22 14:27:31 | 只看該作者
Mutant Mouse Models in Evaluating Novel Approaches to Antipsychotic Treatment,enetics of schizophrenia and mutant models relating to replicable risk genes. Lastly, we extend this discussion by exemplifying two new variant approaches in mutant mice that may serve as prototypes for advancing antipsychotic drug development. There is continuing need not only to address numerous t
7#
發(fā)表于 2025-3-22 17:42:53 | 只看該作者
8#
發(fā)表于 2025-3-22 22:48:58 | 只看該作者
The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions,iating positive symptoms is still unsettled, selective D. receptor antagonism has therapeutic features for schizophrenia and beyond as demonstrated by several animal models: improved cognitive function, emotional processing, executive function, flexibility, and social behavior. D. receptor antagonis
9#
發(fā)表于 2025-3-23 03:18:20 | 只看該作者
10#
發(fā)表于 2025-3-23 08:09:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
客服| 孟津县| 京山县| 南通市| 定结县| 慈利县| 武宣县| 阿克苏市| 清远市| 洛浦县| 原阳县| 无棣县| 噶尔县| 东乌| 井陉县| 广丰县| 余干县| 黔南| 延边| 香格里拉县| 澎湖县| 宜兰县| 淳化县| 申扎县| 永修县| 古交市| 沙田区| 康马县| 霍林郭勒市| 杭州市| 清原| 沂源县| 怀柔区| 保山市| 敦化市| 阿克| 昌图县| 万山特区| 合肥市| 梁河县| 麟游县|